☆ 4.7 Letter

Intratumoral heterogeneity as a predictive biomarker in anti-PD-(L)1 therapies for non-small cell lung cancer

MOLECULAR CANCER (2021)

Get Full Text
Add to Collection

Journal

MOLECULAR CANCER
Volume 20, Issue 1, Pages -

Publisher

BMC
DOI: 10.1186/s12943-021-01331-9

Keywords

-

Categories

Biochemistry & Molecular Biology Oncology

Funding

  1. Chinese National Natural Science Foundation project [81872499, 81772476, 81972898, 81972556]
  2. China Postdoctoral Science Foundation [2020M683122]
  3. Natural Science Funds of Guangdong Province [2019A1515011090]
  4. Medical Scientific Research Foundation of Guangdong Province [C2018062]
  5. Outstanding Young Talents Program of Sun Yat-sen University Cancer Center [16zxyc04]

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.